Interpretation of Intact PTH Level of 92 pg/mL
An intact PTH level of 92 pg/mL requires interpretation in the context of serum calcium, phosphate, renal function, and the specific assay used, as this value falls in different clinical zones depending on the underlying condition.
Clinical Context Determines Significance
The meaning of PTH 92 pg/mL varies dramatically based on the clinical scenario:
In Normal Renal Function (Non-CKD Patients)
- PTH 92 pg/mL is elevated when the typical upper limit of normal for intact PTH assays is approximately 65 pg/mL 1.
- This elevation suggests primary hyperparathyroidism if accompanied by hypercalcemia or inappropriately normal calcium levels 1.
- The diagnosis of primary hyperparathyroidism relies on demonstrating PTH that is abnormally high relative to the calcium concentration, not just the absolute PTH value 1.
- If calcium is normal or low, consider secondary causes: vitamin D deficiency, malabsorption, chronic hypocalcemia, or early chronic kidney disease 2.
In Chronic Kidney Disease (CKD G3a-G5, Not on Dialysis)
- PTH 92 pg/mL may be appropriate or even desirable in CKD patients not yet on dialysis 2.
- Guidelines recommend evaluating patients with PTH progressively rising or persistently above the upper normal limit for modifiable factors including hyperphosphatemia, hypocalcemia, high phosphate intake, and vitamin D deficiency 2.
- Elevated PTH levels are necessary to maintain normal bone remodeling in uremia—studies show that approximately 165 pg/mL (2.5-fold above normal) defines the upper normal limit of bone turnover in uremic patients 3.
- PTH 92 pg/mL in CKD G3-G4 typically does not require aggressive intervention unless progressively rising 2.
In Hemodialysis Patients (CKD G5D)
- PTH 92 pg/mL is too low for dialysis patients 2, 4.
- KDIGO guidelines recommend maintaining intact PTH levels in the range of 2 to 9 times the upper normal limit (approximately 130-585 pg/mL if using 65 pg/mL as upper normal) 2.
- Low PTH levels (<150 pg/mL) are associated with increased mortality risk in hemodialysis patients, with hazard ratios of 2.06 for all-cause mortality and 1.82 for cardiovascular events 5.
- PTH levels below 150 pg/mL correlate with low-turnover bone disease (adynamic bone disease) in 83-88% of cases 6, 3.
- The optimal PTH range for lowest mortality risk in incident hemodialysis patients is 150-450 pg/mL 4.
Critical Assay Considerations
PTH measurement is not standardized across laboratories, which significantly impacts interpretation 1:
- Different generation assays (second vs. third generation) measure PTH fragments to varying degrees 1.
- The same PTH level measured in different laboratories can yield different clinical decisions, particularly in CKD where guidelines use fold-increases above normal 1.
- Always compare results to the specific reference range of the laboratory performing the assay 1.
Essential Concurrent Laboratory Evaluation
To properly interpret PTH 92 pg/mL, you must measure:
- Serum calcium (total and ionized) to distinguish primary from secondary hyperparathyroidism 1, 2.
- Serum phosphate to assess for hyperphosphatemia driving secondary hyperparathyroidism 2.
- Serum creatinine/eGFR to determine CKD stage 2.
- 25-hydroxyvitamin D to identify vitamin D deficiency as a correctable cause 2.
- Serum albumin if using total calcium (to correct for protein binding) 2.
Common Pitfalls to Avoid
- Do not interpret PTH in isolation—the calcium level is essential for determining if PTH is appropriately suppressed or inappropriately elevated 1.
- Do not apply the same PTH targets across different CKD stages—what is normal for CKD G3 is dangerously low for dialysis patients 2, 4, 5.
- Do not assume all PTH assays are equivalent—lack of standardization means reference ranges vary between laboratories 1.
- Do not aggressively suppress PTH in dialysis patients to "normal" levels—this increases mortality risk and causes adynamic bone disease 4, 5, 6.